fashion -WSS

fashion

author：explore 2025-08-27 16:48:03 - browse：64

Fatty liver foregrounds arteries and veins surrounded by red blood cells — health coverage from STAT — Adobe

As drugmakers race to join the obesity drug market ignited by the approval of Wegovy and Zepbound, they’re not just competing on their drugs’ weight loss effects. They’re also competing on their products’ ability to treat a severe form of liver disease.

A new update of the STAT Obesity Drug Tracker shows that at least 23 — about one-fifth — of the 105 obesity treatments in development or on the market are also being investigated for metabolic dysfunction-associated steatohepatitis, the fatty liver disease known as MASH (and previously called NASH).

In this update, STAT has added a category — “other diseases investigated” — to show conditions beyond obesity for which a compound is being studied. Type 2 diabetes is the most common – it’s long been linked to obesity, and the latest GLP-1 treatments like Wegovy and Zepbound were initially developed as diabetes drugs. But behind diabetes, the next most common disease under investigation for obesity candidates is MASH.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Listen: Your guide to Wegovy's blockbuster heart study

focus

WSS

GOP presidential candidates start declaring their loyalty

Faced with fears of OxyContin misuse, sales reps touted its safety

Novo Nordisk obesity pill bests Wegovy in early trial

After John Oliver segment, STAT readers share their opioid

Some of the ways extreme heat will change life as we know it

Listen: Your guide to Wegovy's blockbuster heart study

knowledge

fashion

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Change Healthcare cyberattack prompts Medicare loan program

Anesthesiologist group: stop taking Ozempic before surgery

What it’s like to watch children die of measles

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NEJM study link tiny plastics in blood vessels to heart problems

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Malaria cases in Florida and Texas: Here’s what you need to know

Change Healthcare cyberattack prompts Medicare loan program

hotspot

Timeline: Special counsel's investigation into Trump's handling of classified documents

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Genentech weighs delaying cancer therapy after drug pricing law

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

The perfect storm of weather conditions that led to the devastating wildfires in Maui

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Wikipedia

Wikipedia

focus

focus